Go to content
To the homepage of National Health Care Institute
National Health Care Institute
Home
Publications
Enter what you are looking for
Icatibant (Firazyr) for the treatment of hereditary angio-oedema (HAE)
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.
Download:
Icatibant (Firazyr) for the treatment of hereditary angio-oedema (HAE)
Report
24-10-2010
PDF document
82.18 KB